Peptides

Showing 13–24 of 51 results

• 
  API

  Elamipretide

  CAS:736992-21-5

  Status:R&D

  Indications:Tumor
• 
  API

  Eptifibatide

  CAS:188627-80-7

  Status:DMF, NMPA, WC

  Indications:Diseases of the circulatory system
• 
  API

  Etelcalcetide

  CAS:1262780-97-1

  Status:DMF (2025)

  Indications:Diseases of the urogenital system
• 
  API

  Exenatide

  CAS:141758-74-9

  Status:NMPA

  Indications:Endocrine, nutritional, and metabolic diseases
• 
  API

  Ganirelix

  CAS:124904-93-4
  Status:DMF, ASMF, TGA, NMPA, WC
  Indications:Pregnancy, childbirth, and puerperium

• 
  API

  Glatiramer

  CAS:147245-92-9

  Status:DMF

  Indications:Nervous System Diseases
• 
  API

  Glepaglutide

  CAS:914009-86-2

  Status:R&D

  Indications:Digestive System Diseases
• 
  API

  Glucagon

  CAS:9007-92-5

  Status:NMPA

  Indications:Endocrine, nutritional, and metabolic diseases
• 
  API

  Lanreotide

  CAS:108736-35-2

  Status:DMF (2025)

  Indications:Tumors, as well as endocrine, nutritional, and metabolic diseases
• 
  API

  Leuprorelin

  CAS:53714-56-0

  Status:CEP

  Indications:Tumors and diseases of the urogenital system
• 
  API

  Linaclotide

  CAS:851199-59-2

  Status:DMF, NMPA, WC

  Indications:Diseases of the digestive system
• 
  API

  Liraglutide

  CAS:204656-20-2
  Status:DMF, TGA, NMPA, WC
  Indications:Endocrine, nutritional, and metabolic diseases